What is Counterstrain?
Counterstrain operates at the intersection of advanced manual therapy and professional medical education. Since its inception in 2008, the company has served as a primary developer and advocate for the Counterstrain technique, a specialized approach to treating musculoskeletal and systemic dysfunction. Beyond direct patient care, the organization maintains the Counterstrain Academy, a dedicated educational arm that provides mastery programs and ongoing training for healthcare professionals. By integrating clinical practice with high-level pedagogical support, Counterstrain has established a unique market position that bridges the gap between traditional physical therapy and innovative, system-specific manual interventions.
How much funding has Counterstrain raised?
Counterstrain has raised a total of $43K across 1 funding round:
Debt
$43K
Debt (2021): $43K with participation from PPP
Key Investors in Counterstrain
PPP
Public-Private Partnership
What's next for Counterstrain?
With the recent influx of capital, Counterstrain is poised to accelerate its operational expansion and enhance its educational infrastructure. The strategic roadmap likely involves scaling the Counterstrain Academy to meet the rising demand for specialized manual therapy certifications, alongside potential geographic expansion of its clinical facilities. By investing in both human capital and technological support for its training programs, the company aims to solidify its status as a leader in the manual therapy domain. Future growth will likely focus on deepening the application of its techniques to additional body systems, thereby increasing the clinical utility and market reach of its proprietary methodology. This phase of development is critical for transitioning the brand into a broader, more integrated healthcare service provider.
See full Counterstrain company page
